GRM5 and Alzheimer disease: As an extension of our previous work showing synaptic density and mGluR5 reductions in AD, we performed analyses to investigate the spatial relationships between both biomarkers in a cohort of individuals who underwent both [18F]FPEB and [11C]UCB-J PET.